A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer

Cancer Centers of the Carolinas CCC Faris, Greenville

Sarah Cannon Research Institute Dept.ofSarahCannonCancerCtr(2), Nashville

Novartis Investigative Site, Essen

Novartis Investigative Site, Valencia

Novartis Investigative Site, Valencia

Baylor Health Care System/Sammons Cancer Center Baylor- Sammons, Dallas

Tyler Cancer Center TCC, Tyler

Nevada Cancer Institute NVCC - Huntsman, Las Vegas

University of California at Los Angeles JonssonComprehensiveCancerCtr, Los Angeles

Yale University School of Medicine YaleCancerCtr-ClinTrialsOffice, New Haven

Dana Farber Cancer Institute Clinical Trials ProjectManager, Boston

University of Texas/MD Anderson Cancer Center Thoractic Head/Neck Med.Onc(2), Houston

Novartis Investigative Site, Amsterdam

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Manchester